Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $AMRX vs $INDV | Chartloom

Compare

$AMRX vs $INDV

Amneal Pharmaceuticals Inc · Indivior Pharmaceuticals, Inc

AMRX

Amneal Pharmaceuticals Inc

INDV

Indivior Pharmaceuticals, Inc

Compare $AMRX vs $INDV

Comparing Amneal Pharmaceuticals Inc and Indivior Pharmaceuticals, Inc

AMRXAmneal Pharmaceuticals Inc

INDVIndivior Pharmaceuticals, Inc

AMRXAmneal Pharmaceuticals Inc

Market cap

$6.25B

P/E (TTM)

40.80x

Forward P/E (NTM)

19.08x

Forward P/S (NTM)

1.89x

Rev growth (TTM)

9.3%

YTD performance

54.6%

52W performance

96.3%

FCF yield

-0.2%

INDVIndivior Pharmaceuticals, Inc

Market cap

$4.29B

P/E (TTM)

12.37x

Forward P/E (NTM)

7.50x

Forward P/S (NTM)

3.13x

Rev growth (TTM)

13.6%

YTD performance

-0.9%

52W performance

48.9%

FCF yield

-2.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AMRX

INDV

Detailed metrics comparison

AMRX

Amneal Pharmaceuticals Inc

INDV

Indivior Pharmaceuticals, Inc

Market Cap

AMRX$6.25B

INDV$4.29B

Enterprise Value

AMRX$8.85B

INDV$4.55B

Price

AMRX$19.57

INDV$35.42

P/E Ratio

AMRX40.80x

INDV12.37x

P/S Ratio

AMRX2.00x

INDV3.22x

EV/Sales

AMRX2.84x

INDV3.42x

EV/EBITDA

AMRX13.14x

INDV10.26x

P/B Ratio

AMRX192.54x

INDV422.91x

P/FCF Ratio

AMRXN/A

INDVN/A

EV/FCF

AMRX-719.11x

INDV-41.75x

PEG Ratio

AMRX1.98x

INDV0.41x

Forward P/E (NTM)

AMRX19.08x

INDV7.50x

Forward P/S (NTM)

AMRX1.89x

INDV3.13x

Revenue (TTM)

AMRX$3.12B

INDV$1.33B

Revenue Growth (YoY)

AMRX9.3%

INDV13.6%

Forward Rev Growth

AMRX9.0%

INDV5.4%

Gross Margin (TTM)

AMRX39.3%

INDV82.0%

Operating Margin (TTM)

AMRX14.6%

INDV30.3%

EBITDA Margin (TTM)

AMRX21.6%

INDV33.1%

Net Margin (TTM)

AMRX5.0%

INDV26.7%

FCF Margin (TTM)

AMRX-0.4%

INDV-8.2%

Net Income (TTM)

AMRX$157M

INDV$355M

FCF (TTM)

AMRX$-12M

INDV$-109M

EPS (TTM)

AMRX$0.48

INDV$2.86

ROE (TTM)

AMRX174.6%

INDV159.1%

ROA (TTM)

AMRX4.3%

INDV28.1%

ROIC (TTM)

AMRX2.1%

INDV29.4%

Cash

AMRX$128M

INDV$222M

Debt

AMRX$2.73B

INDV$487M

Net Cash/Debt

AMRX$-2.60B

INDV$-265M

Current Ratio (TTM)

AMRX2.20x

INDV0.84x

Quick Ratio (TTM)

AMRX1.38x

INDV0.65x

Debt/Equity (TTM)

AMRX82.62x

INDV27.90x

Debt/Assets (TTM)

AMRX0.0%

INDV0.0%

Interest Coverage (TTM)

AMRXN/A

INDVN/A

Net Debt/EBITDA (TTM)

AMRX0.00x

INDV0.00x

Beta

AMRX1.22

INDV0.49

52W Performance

AMRX96.3%

INDV48.9%

YTD Performance

AMRX54.6%

INDV-0.9%

% from 52W High

AMRX-7.6%

INDV-17.3%

% from 52W Low

AMRX104.7%

INDV50.4%

Asset Turnover (TTM)

AMRX0.85x

INDV1.06x

FCF Yield (TTM)

AMRX-0.2%

INDV-2.5%

Earnings Yield (TTM)

AMRX2.5%

INDV8.3%

Dividend Yield (TTM)

AMRXN/A

INDVN/A

Rule of 40

AMRX8.9

INDV5.4

EV/GP/RG

AMRX1.16

INDV1.40

Ticker research

View AMRX research View INDV research

Metric	AMRX Amneal Pharmaceuticals Inc	INDV Indivior Pharmaceuticals, Inc
Market & Valuation
Market Cap	$6.25B	$4.29B
Enterprise Value	$8.85B	$4.55B
Price	$19.57	$35.42
P/E Ratio	40.80x	12.37x
P/S Ratio	2.00x	3.22x
EV/Sales	2.84x	3.42x
EV/EBITDA	13.14x	10.26x
P/B Ratio	192.54x	422.91x
P/FCF Ratio	N/A	N/A
EV/FCF	-719.11x	-41.75x
PEG Ratio	1.98x	0.41x
Forward P/E (NTM)	19.08x	7.50x
Forward P/S (NTM)	1.89x	3.13x
Revenue & Growth
Revenue (TTM)	$3.12B	$1.33B
Revenue Growth (YoY)	9.3%	13.6%
Forward Rev Growth	9.0%	5.4%
Profitability
Gross Margin (TTM)	39.3%	82.0%
Operating Margin (TTM)	14.6%	30.3%
EBITDA Margin (TTM)	21.6%	33.1%
Net Margin (TTM)	5.0%	26.7%
FCF Margin (TTM)	-0.4%	-8.2%
Net Income (TTM)	$157M	$355M
FCF (TTM)	$-12M	$-109M
EPS (TTM)	$0.48	$2.86
ROE (TTM)	174.6%	159.1%
ROA (TTM)	4.3%	28.1%
ROIC (TTM)	2.1%	29.4%
Financial Health
Cash	$128M	$222M
Debt	$2.73B	$487M
Net Cash/Debt	$-2.60B	$-265M
Current Ratio (TTM)	2.20x	0.84x
Quick Ratio (TTM)	1.38x	0.65x
Debt/Equity (TTM)	82.62x	27.90x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.22	0.49
52W Performance	96.3%	48.9%
YTD Performance	54.6%	-0.9%
% from 52W High	-7.6%	-17.3%
% from 52W Low	104.7%	50.4%
Efficiency & Yields
Asset Turnover (TTM)	0.85x	1.06x
FCF Yield (TTM)	-0.2%	-2.5%
Earnings Yield (TTM)	2.5%	8.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	8.9	5.4
EV/GP/RG	1.16	1.40
Ticker research	View AMRX research	View INDV research

Valuation

P/E Ratio

INDV

12.37x

AMRX

40.80x

P/S Ratio

AMRX

2.00x

INDV

3.22x

EV/FCF

AMRX

-719.11x

INDV

-41.75x

Growth & revenue

Revenue Growth TTM

INDV

13.6%

AMRX

9.3%

Forward Revenue Growth

AMRX

9.0%

INDV

5.4%

Profitability & performance

Gross Margin

INDV

82.0%

AMRX

39.3%

ROE

AMRX

174.6%

INDV

159.1%

FCF Yield %

AMRX

-0.2%

INDV

-2.5%

52-Week Performance

AMRX

96.3%

INDV

48.9%

Detailed metrics comparison

AMRX

Amneal Pharmaceuticals Inc

INDV

Indivior Pharmaceuticals, Inc

Market Cap

AMRX$6.25B

INDV$4.29B

Enterprise Value

AMRX$8.85B

INDV$4.55B

Price

AMRX$19.57

INDV$35.42

P/E Ratio

AMRX40.80x

INDV12.37x

P/S Ratio

AMRX2.00x

INDV3.22x

EV/Sales

AMRX2.84x

INDV3.42x

EV/EBITDA

AMRX13.14x

INDV10.26x

P/B Ratio

AMRX192.54x

INDV422.91x

P/FCF Ratio

AMRXN/A

INDVN/A

EV/FCF

AMRX-719.11x

INDV-41.75x

PEG Ratio

AMRX1.98x

INDV0.41x

Forward P/E (NTM)

AMRX19.08x

INDV7.50x

Forward P/S (NTM)

AMRX1.89x

INDV3.13x

Revenue (TTM)

AMRX$3.12B

INDV$1.33B

Revenue Growth (YoY)

AMRX9.3%

INDV13.6%

Forward Rev Growth

AMRX9.0%

INDV5.4%

Gross Margin (TTM)

AMRX39.3%

INDV82.0%

Operating Margin (TTM)

AMRX14.6%

INDV30.3%

EBITDA Margin (TTM)

AMRX21.6%

INDV33.1%

Net Margin (TTM)

AMRX5.0%

INDV26.7%

FCF Margin (TTM)

AMRX-0.4%

INDV-8.2%

Net Income (TTM)

AMRX$157M

INDV$355M

FCF (TTM)

AMRX$-12M

INDV$-109M

EPS (TTM)

AMRX$0.48

INDV$2.86

ROE (TTM)

AMRX174.6%

INDV159.1%

ROA (TTM)

AMRX4.3%

INDV28.1%

ROIC (TTM)

AMRX2.1%

INDV29.4%

Cash

AMRX$128M

INDV$222M

Debt

AMRX$2.73B

INDV$487M

Net Cash/Debt

AMRX$-2.60B

INDV$-265M

Current Ratio (TTM)

AMRX2.20x

INDV0.84x

Quick Ratio (TTM)

AMRX1.38x

INDV0.65x

Debt/Equity (TTM)

AMRX82.62x

INDV27.90x

Debt/Assets (TTM)

AMRX0.0%

INDV0.0%

Interest Coverage (TTM)

AMRXN/A

INDVN/A

Net Debt/EBITDA (TTM)

AMRX0.00x

INDV0.00x

Beta

AMRX1.22

INDV0.49

52W Performance

AMRX96.3%

INDV48.9%

YTD Performance

AMRX54.6%

INDV-0.9%

% from 52W High

AMRX-7.6%

INDV-17.3%

% from 52W Low

AMRX104.7%

INDV50.4%

Asset Turnover (TTM)

AMRX0.85x

INDV1.06x

FCF Yield (TTM)

AMRX-0.2%

INDV-2.5%

Earnings Yield (TTM)

AMRX2.5%

INDV8.3%

Dividend Yield (TTM)

AMRXN/A

INDVN/A

Rule of 40

AMRX8.9

INDV5.4

EV/GP/RG

AMRX1.16

INDV1.40

Ticker research

View AMRX research View INDV research

Metric	AMRX Amneal Pharmaceuticals Inc	INDV Indivior Pharmaceuticals, Inc
Market & Valuation
Market Cap	$6.25B	$4.29B
Enterprise Value	$8.85B	$4.55B
Price	$19.57	$35.42
P/E Ratio	40.80x	12.37x
P/S Ratio	2.00x	3.22x
EV/Sales	2.84x	3.42x
EV/EBITDA	13.14x	10.26x
P/B Ratio	192.54x	422.91x
P/FCF Ratio	N/A	N/A
EV/FCF	-719.11x	-41.75x
PEG Ratio	1.98x	0.41x
Forward P/E (NTM)	19.08x	7.50x
Forward P/S (NTM)	1.89x	3.13x
Revenue & Growth
Revenue (TTM)	$3.12B	$1.33B
Revenue Growth (YoY)	9.3%	13.6%
Forward Rev Growth	9.0%	5.4%
Profitability
Gross Margin (TTM)	39.3%	82.0%
Operating Margin (TTM)	14.6%	30.3%
EBITDA Margin (TTM)	21.6%	33.1%
Net Margin (TTM)	5.0%	26.7%
FCF Margin (TTM)	-0.4%	-8.2%
Net Income (TTM)	$157M	$355M
FCF (TTM)	$-12M	$-109M
EPS (TTM)	$0.48	$2.86
ROE (TTM)	174.6%	159.1%
ROA (TTM)	4.3%	28.1%
ROIC (TTM)	2.1%	29.4%
Financial Health
Cash	$128M	$222M
Debt	$2.73B	$487M
Net Cash/Debt	$-2.60B	$-265M
Current Ratio (TTM)	2.20x	0.84x
Quick Ratio (TTM)	1.38x	0.65x
Debt/Equity (TTM)	82.62x	27.90x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.22	0.49
52W Performance	96.3%	48.9%
YTD Performance	54.6%	-0.9%
% from 52W High	-7.6%	-17.3%
% from 52W Low	104.7%	50.4%
Efficiency & Yields
Asset Turnover (TTM)	0.85x	1.06x
FCF Yield (TTM)	-0.2%	-2.5%
Earnings Yield (TTM)	2.5%	8.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	8.9	5.4
EV/GP/RG	1.16	1.40
Ticker research	View AMRX research	View INDV research